Effect of Proton Pump Inhibitors on Gut Microbiota Composition and Metabolites in Healthy Subjects Using CapScan

Trial statusNot yet recruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexAll
Age18-85
SponsorEnvivo Bio Inc

About this trial

This study is designed to evaluate the effect of proton pump inhibitors on the regional composition of the gut microbiota and metabolic profiles of health volunteers using the CapScan collection capsule.

Eligibility criteria

Qualifiers

Males or females 18 years of age or older and 85 years of age or younger at the time of the first Screening Visit.

ASA Classification 1 or 2.

For women of childbearing potential, negative urine pregnancy test within 7 days of Screening Visit. Willingness to use highly effective contraception during the entire study period (e.g.: implants, injectables, oral contraceptives, intra-uterine device or declared abstinence).

Subject is fluent in English and understands the study protocol and informed consent and is willing and able to comply with study requirements and sign the informed consent form.

Disqualifiers

prior gastric or esophageal surgery, including bariatric surgery

bowel obstruction

gastric outlet obstruction

gastroparesis

Trial design

Treatments tested in this trial

  • CapScan

Treatment groups

No treatment groups listed

Sponsors and collaborators